May 2, 2024 | Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…

The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.
New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.
With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.
Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Dive into 2025’s cutting-edge medical education technologies like immersive training, interactive data visualization, and microlearning. Discover how to boost engagement and drive real HCP impact.
Creatively engage your advisors while deepening medical understanding! Dive into virtual journal clubs and case studies to analyze patient scenarios, dissect new research, and gain critical feedback on your brand…
Optimize product strategy! Discover how virtual profiling can accurately map treatment pathways and pinpoint opportunities for your innovations while engaging your advisors in a creative way!
Want to truly engage and educate HCPs? Learn to avoid costly mistakes and be at the forefront of learning by creating a dynamic platform that captures their attention and drives…
Improve patient experiences! Learn how to co-create patient journey maps with your advisors virtually, identify healthcare gaps, and streamline care pathways.
Virtual publication planning is rapidly evolving with new digital tools, but are you truly optimizing your strategy? Our article dives into the challenges of this new landscape, from data security…
Tired of traditional advisory board limitations? Explore innovative ways to engage your KOLs, HCPs, and MSLs in our new series! Learn how to co-create impactful publications virtually in our first…
Struggling to quantify the value of your medical education platform and prove its ROI? Join our upcoming Pharma-exclusive webinar to learn real-work strategies and tips for developing a Med Ed…
Who says remote work can’t be fun? Discover creative ways to boost morale and keep your life sciences team engaged with virtual activities!
Tired of the disconnect in virtual meetings? Discover how using webcams can enhance communication, build stronger relationships, and create a more engaging work environment.
